HAVN Life enters supply agreement with Atman Retreats
by CM Staff
The first shipments to Atman are scheduled for delivery in May 2022 to support retreats that are already scheduled.
VANCOUVER — HAVN Life Sciences Inc. has entered into a supply partnership with Atman Retreat, a retreat centre helping people explore psychedelics therapeutically.
HAVN Life will supply psilocybin for use during Atman Retreat programs, which operate in compliance with local and international protocols. HAVN Life will provide Atman from its facility in Jamaica, where mushrooms are cultivated under GACP and processed in a GMP facility.
The first shipments to Atman are scheduled for delivery in May 2022 to support retreats that are already scheduled.
“Our Supply Partnership with Atman Retreat is a natural fit,” said Dr. Ivan Casselman, chief psychedelic officer at HAVN Life in a statement.
“For the past year, HAVN Labs has been working towards developing a global supply of psilocybin mushrooms and related products. In addition to our local partnerships with Hypha Wellness and GMP manufacturer P.A. Benjamin, we are keen to support and collaborate with other companies within Jamaica’s psychedelic space – one that we believe has huge potential,” he added.
